Upload
monicayusilina
View
234
Download
0
Embed Size (px)
Citation preview
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 1/30
MORNING REPORT
CASE
Oktober 9th
2014
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 2/30
PATIENT’SIDENTITY Name : I!
A"e : #0 $o
Ge%&er : ma'e
Stat() : Marr*e&
Re'*"*o% : +*%&( A&&re)) : Sa'ema&e", Taba%a%
T- : # oktober 2014 1./00
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 3/30
ANAMNESIS+eteroa%am%e)*)
Ch*e -om3'a*% :
bo&$ eak%e))
Pre)e%t h*)tor$ : Patient came to the emergency unit
BRSU Tabanan with chief complain bodyweakness. Patien complain weakness 3
days BAT weakness fell all o!er thebody he can"t do any acti!ity. Patien alsocomplain nausea since 3 days BAT. Thiscomplain cause the patient can"t eat.
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 4/30
#ont"d
e also felt nausea without !omitingsince 3 days. $t felt almost e!erydayand it worsen by food consumption
and he also complain loss ofappetite.
%e!er& headache& shortness of
breath was denied Urination and defecation were said
to be normal. Bloody urine& pain
since urinating and blackish stool
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 5/30
Pa)t *''%e)) h*)tor$ istory of the same complain was
denied by the patient. patients had a
history of taking medication arthritis for'( years& but the patient forgot thename of the medicine and patients hada history of gastritis
istory of )*& hipertension& heartdisease was denied.
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 6/30
5am*'$ h*)tor$ : +one of the family member had the same
complained as the patient
istory of T& kidney& ,$ Tract and )* wasdenied
So-*a' +*)tor$ : Patient is a farmer. e consumption of
cigarettes since young . now he smoke -cigarettes per day. #onsumption alkohol was
denied
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 7/30
P+YSICA6 E7AMINATION
Ge%era' a33eara%-e : Mo&erate'$ *''
6e8e' o -o%)-*o()%e)):Com3o) Me%t*)
GCS : E4M;
*ta' S*"%:
BP '((/0( mmg
RR -( 1/min
PR '(2 1/min ta1 30#
4eight 55 kg
eight '05 cm
B*$ -(&-( kg/m-
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 8/30
E$e) : a%em*)<=<> *-ter() ?=?>
R3 <=< *)o-or*-, oe&ema 3a'3/?=?
ENT : To%)*') T1=T1> 3har$%"ea'h$3erem*a ?> to%"(e %orma'> '*3
-$a%o)*) ?
Ne-k : @P RP < 2 -m+2O>
'$m3h %o&e e%'ar"eme%t ?
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 9/30
Thora : S*metr*), retra-t*o% ?Cor
$nspection $ctus cordis unseenPalpation $ctus cordis not palpablePercussion
6B at *#6 S $#S 7
RB at PS6 )Auscultation S' S- single regular& murmur 89:
Po
$nspection SymetricPalpation 7% +/ +Percussion sonor/sonorAuscultation 7es ; / ; & Rh 9/9& wh 9/9
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 10/30
Ab&ome% :
$nspection )istention 89:< ascites 89:
Auscultation Bowel sounds 8;: normal
Percussion TympaniPalpation Tenderness on palpation 8;:on epigastium< li!er = spleen not
palpable
Ballotment 89/9:
Etrem*t*e): 4arm ;/;< edema 9/9
;/; ;/;
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 11/30
Com3'ete b'oo& -o(%tParamet
erRe)('t B%*t Remark) Reere%-e
ra%"e
!C 2/2 10.=6 + 4?10
-Ne , 21/ 10.=6 + 4#,00 F 0,00
-6$ 10,4 2/; 10.=6 1.,0 F 40,0
-Mo ./;. 0,919 10.=6 2,00 F 10,00
-Eo 0/0; 0,01 10.=6 0,00 F ,00
-!a 0,41
0114 10.=6 0,0 0 F 2,00
R!C ./.. 10;=6 6 4,0 F ,0
+G! 9/2 "=&6 6 1.,00 F 1;,00+CT .0 6 40,00 F 4,00
MC 90/0 6 0,00 F100,00
MC+ 2#/# 3" 2;,00 F .4,00
MC+C .0/ "=&6 6 .2,00 F .;,00
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 12/30
!'oo& -hem*)tr$ 3a%e'
Parameter Re)('t B%*t Remark) Reere%-era%"e
SGOT B=6 0?0
SGPT 1# B=6 + 0?0
!BN .4 m"=&6 + ?1
Creat*%*%e 2/2 m"=&6 + 0,;0 F 1,10
G'(ko)a 111 m"=&6 + #4?10;
Natr*(m 1. Mmo'=6
1.?1
a'*(m /4 Mmo'=6
.,?,
Ch'or*&a 10; Mmo'=6
+ 9?10
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 13/30
>#,
sinus tachycardia 8'(2 1/minute:
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 14/30
ASSESMENT
*ild anemia normokromik normositer
6eukositosis
#hronic kidney disease stage $7
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 15/30
P6ANNING
Thera3$ ospitali?ed
$7%) +a#l (.@ -( drops/mnt
#aftria1one -1 'gr
%olic acid -1' tab
Pantopra?ole '1' tab
ndansentron 312mg
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 16/30
P&
?
Mo%*tor*%" 7ital sign
#omplaints
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 17/30
T+AN YOB
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 18/30
Criteria :
1. Kidney damage for≥
3 month• structural and functional abnormality
• with or without decreased Glomerular Filration
Rate (GFR)
• manifest by either abnormality of :
• athology
• blood comosition
• urine comosition
• imaging test
!. GFR " #$ ml%min for 3 month& with or without 'idney
damage
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 19/30
lanation :
• *tructural abnormality e.g. single 'idney&
'idney%ureter stone& cystic 'idney&
roteinuria
• +rostate hyertrohy& etc
• GFR : calculated by Koc'roft Gault Formula
• ,lood comosition e.g. ureum& creatinin
• -rine comosition e.g. roteinuria& haematuria
• maging e.g. ,/0 (lain hoto abdomen)& -*G etc
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 20/30
Kidney disease ≥ 3 month :
GFR (Coc'roft Gault)
≥
#$ ml%mnt%1.3 m!
Kidney damage (2) CK4
Kidney damage () normal
" #$ ml%mnt%1.3 m! CK4
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 21/30
Stage Description GFR
(mL/min/1.73 m2)
Actions*
I Kine! amage "it#
norma$ or GFR
≥ %& Diagnosis an treatment. 'reatment o
comori conitions S$o"ing
progression +,D ris- rection
II Kine! amage "it# mi$
GFR
&0% stimating progression
III oerate GFR 3&04% 5a$ating an treating comp$ications
I, Se5ere GFR 1402% 6reparation or -ine! rep$acement
t#erap!
, Kine! ai$re 14 or ia$!sis Rep$acement (i remia pesent)
*56G* 0F CK4: 6 C7/C67 6C50/ +76/
+#ronic Kine! Disease is eine as eit#er -ine! amage or GFR & mL/min/1.73 m2 or≥
3
mont#s. Kine! amage is eine as pat#o$ogic anorma$ities or mar-ers o amage inc$ing
anorma$ities in $oo or rine test or imaging sties
* Inc$es actions rom proceeing stages
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 22/30
5070G8 0F CK4
tiology of CK4 are :
1. 4iabetes 9ellitus!. Chronic Glomerulonehritis
3. Chronic +yelonehritis
. ;yertension
<. -rinary tract stone
#. 0bstruction (tumor& rostate)
. mmunological disease (*7)
=. Congenital (olycystic 'idney)
>. 9alignancy
1$. 0thers :
• regnancy
•
chronic li?er disease
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 23/30
7/C67 96/F*5650/ :
ymtom :
/ot secific : lethargic& wea'ness. nausea& ?omiting& headache&
edema& dysneu on effort
+hysical eamination :
;yertension& anemic& edema*ign of comlications e.g. heart hyertrohy& ascites
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 24/30
+atohysiology of hyertension in CK4
1. *odium retention
fail of the 'idney for ecreted water and sodium
ecess
!. 6cceleration of Renin 6ngiotensin *ystem acti?ity
increased secretion of renin
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 25/30
6ngiotensinogen
(roduced by li?er)
Renin(roduced by 'idney
6ngiotensin
6ngiotensin
Con?erting n@yme
(6C)
Renin Angiotensin Aldosterone System
*urarenal corte
6ldosteron
6ngiotensin
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 26/30
+65;0+;8*070G8 0F 6/96 / CK4
1. rythrooitin insufficiency
decreased of erythrooitin secreted by the 'idney
!. ron deficiency
chronic bleeding
low inta'e
3. 0thers haemolysis % decreased of erythrocyte li?e send
deressed of bone marrow by uraemic substances
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 27/30
+atients with chronic 'idney disease should be
e?aluated to determine:
1. 4iagnosis (tye of 'idney disease)
!. Comorbid conditionsA
3. *e?erityA assessed by le?el of 'idney functionA
. Comlications& related to le?el of 'idney functionA
<. Ris' for loss of 'idney functionA
#. Ris' for cardio?ascular disease
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 28/30
C09+7C650/ 0F CK4
1. Cardiac diseases
coronary artery disease congesti?e heart disease
acute left heart failure
!. 9etabolic acidosis
3. lectrolyte imbalance
hyer % hyo'alemia
hyer % hyonatremia
. Renal osteodystrohy (renal bone disease)
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 29/30
arly detection of CK4 using 'idney health chec'
Bho is at higher ris'
of 'idney disease
Bhat should be
done
;ow often
6ge <$ 8ears
4iabetes
;igh ,lood +ressure
*mo'ing
0besity
Family history of
'idney disease
,lood ressure
-rine distic'
(mircoalbuminuria if
diabetes resent)
eGFR
?ery 1! months
7/23/2019 MR CKD Tabanan
http://slidepdf.com/reader/full/mr-ckd-tabanan 30/30
5reatment for chronic 'idney disease should include:
1. *ecific theray& based on diagnosis
!. ?aluation and management of comorbid conditionsA
3. *lowing the loss of 'idney function
. +re?ention and treatment of cardio?ascular diseaseA
<. +re?ention and treatment of comlications of decreased
'idney function
#. +rearation for 'idney failure and 'idney relacement
therayA. Relacement of 'idney function by dialysis and
translantation& if signs and symtoms of uremia are
resent